Bank of New York Mellon Corp grew its holdings in Corium International Inc (NASDAQ:CORI) by 33.7% in the 3rd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 88,445 shares of the biopharmaceutical company’s stock after acquiring an additional 22,285 shares during the period. Bank of New York Mellon Corp owned 0.25% of Corium International worth $980,000 as of its most recent SEC filing.
A number of other hedge funds have also bought and sold shares of the business. TIAA CREF Investment Management LLC acquired a new stake in shares of Corium International in the second quarter worth $411,000. Teachers Advisors LLC acquired a new stake in shares of Corium International in the second quarter worth $272,000. EAM Investors LLC acquired a new stake in shares of Corium International in the second quarter worth $563,000. Stonepine Capital Management LLC acquired a new stake in shares of Corium International in the second quarter worth $3,085,000. Finally, New York State Common Retirement Fund acquired a new stake in shares of Corium International in the second quarter worth $158,000. 89.08% of the stock is owned by institutional investors.
A number of analysts have recently weighed in on CORI shares. Needham & Company LLC boosted their price objective on shares of Corium International from $13.00 to $16.00 and gave the stock a “buy” rating in a research note on Monday, November 20th. HC Wainwright set a $15.00 price objective on shares of Corium International and gave the stock a “buy” rating in a research note on Friday, November 17th. Cantor Fitzgerald restated a “buy” rating and issued a $14.00 price objective on shares of Corium International in a research note on Friday, December 22nd. Zacks Investment Research cut shares of Corium International from a “buy” rating to a “sell” rating in a research note on Tuesday, October 10th. Finally, Jefferies Group set a $10.00 price objective on shares of Corium International and gave the stock a “buy” rating in a research note on Sunday, October 29th. One equities research analyst has rated the stock with a sell rating, two have issued a hold rating and six have given a buy rating to the stock. Corium International currently has an average rating of “Buy” and a consensus target price of $12.86.
In related news, major shareholder Healthcare Master Fun Broadfin sold 150,000 shares of the company’s stock in a transaction on Thursday, November 2nd. The shares were sold at an average price of $11.05, for a total transaction of $1,657,500.00. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. 45.70% of the stock is owned by corporate insiders.
Corium International Inc (CORI) opened at $11.95 on Friday. The company has a market cap of $399.25, a price-to-earnings ratio of -7.16 and a beta of 1.26. Corium International Inc has a one year low of $2.67 and a one year high of $12.32. The company has a debt-to-equity ratio of 2.41, a quick ratio of 2.60 and a current ratio of 2.70.
ILLEGAL ACTIVITY WARNING: This story was first published by Dispatch Tribunal and is the property of of Dispatch Tribunal. If you are accessing this story on another website, it was copied illegally and republished in violation of US & international copyright laws. The original version of this story can be read at https://www.dispatchtribunal.com/2018/01/13/bank-of-new-york-mellon-corp-acquires-22285-shares-of-corium-international-inc-cori.html.
Corium International Profile
Corium International, Inc is a commercial-stage biopharmaceutical company focused on the development, manufacture and commercialization of specialty pharmaceutical products. As of September 30, 2016, the Company had multiple programs in preclinical and clinical development focused primarily on the treatment of neurological disorders, with two lead programs in Alzheimer’s disease.
Want to see what other hedge funds are holding CORI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Corium International Inc (NASDAQ:CORI).
Receive News & Ratings for Corium International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Corium International and related companies with MarketBeat.com's FREE daily email newsletter.